Kayne Anderson Rudnick Investment Management
TMDX icon

Kayne Anderson Rudnick Investment Management’s Transmedics TMDX Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-53
Closed -$8.32K – 1024
2024
Q3 		$8.32K Buy
+53
New +$8.17K ﹤0.01% 692

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's TMDX Position: Q4 2024 in Review

Kayne Anderson Rudnick Investment Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 53 shares — an estimated $8.32K sold.

Kayne Anderson Rudnick Investment Management first reported a position in TMDX in Q3 2024 and held it in 1 quarter. The position peaked at $8.32K in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Kayne Anderson Rudnick Investment Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 53 Transmedics shares in Q4 2024, an estimated $8.32K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Transmedics in Q3 2024 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's Transmedics position peaked at $8.32K in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.